SALT LAKE CITY, Aug. 01, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conference: About Recursion Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology…Read More
Recursion Pharmaceuticals to Participate in Upcoming Investor Conference
